Nu Skin Enterprises, Inc. (NUS)
NYSE: NUS · Real-Time Price · USD
5.37
+0.05 (0.94%)
Jun 5, 2026, 4:00 PM EDT - Market closed
Nu Skin Enterprises Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 54.53 | 160.2 | -146.59 | 8.6 | 104.78 | 147.27 |
Depreciation & Amortization | 50.4 | 52.26 | 69.81 | 70.92 | 72.51 | 76.32 |
Stock-Based Compensation | 18.49 | 24.11 | 14.82 | 15.65 | 12.37 | 23.19 |
Other Adjustments | 38.82 | -86.69 | 202.06 | 105.16 | 54.37 | 119.72 |
Change in Receivables | 10.2 | 10.06 | -7.76 | -22.68 | -11.45 | 20.22 |
Changes in Inventories | 6.04 | 11.89 | 30.32 | -13.22 | -2.97 | -126.62 |
Changes in Accounts Payable | -4.92 | -9.11 | -7.29 | -10.08 | 9.26 | -13.28 |
Changes in Accrued Expenses | -48 | -54.32 | -27.58 | -37.7 | -120.83 | -104.99 |
Changes in Other Operating Activities | -49.59 | -28.13 | -16.01 | 2 | -9.97 | -0.25 |
Operating Cash Flow | 75.98 | 80.29 | 111.74 | 118.64 | 108.06 | 141.58 |
Operating Cash Flow Growth | -30.18% | -28.15% | -5.81% | 9.79% | -23.67% | -62.66% |
Capital Expenditures | -34.41 | -34.28 | -41.58 | -58.49 | -59.06 | -68.62 |
Purchases of Investments | -0.57 | - | -14.76 | -16.88 | -13.96 | -16.24 |
Proceeds from Sale of Investments | 8.81 | 10.21 | 18.38 | 18.15 | 5.93 | 15.09 |
Payments for Business Acquisitions | - | - | - | -77.28 | - | -18.96 |
Proceeds from Business Divestments | - | 193.73 | - | - | - | - |
Other Investing Activities | - | 1 | - | - | - | - |
Investing Cash Flow | -25.17 | 170.66 | -37.96 | -134.5 | -67.08 | -88.73 |
Long-Term Debt Issued | 280 | 55 | 15 | 110 | 460 | 155 |
Long-Term Debt Repaid | -295 | -225 | -125 | -10 | - | -115 |
Net Long-Term Debt Issued (Repaid) | -15 | -170 | -110 | 100 | 460 | 40 |
Issuance of Common Stock | -4.91 | -1.91 | -2.06 | 4.56 | 27.05 | 13.86 |
Repurchase of Common Stock | -20.04 | -20.04 | - | -13.01 | -70.05 | -80.42 |
Net Common Stock Issued (Repurchased) | -24.95 | -21.95 | -2.06 | -8.45 | -42.99 | -66.56 |
Common Dividends Paid | -11.71 | -11.83 | -11.93 | -77.62 | -77.02 | -76.27 |
Other Financing Activities | -4.86 | 1.38 | -9.19 | -3.2 | -439.5 | -1.87 |
Financing Cash Flow | -56.51 | -202.4 | -133.18 | 10.73 | -99.5 | -104.7 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | 0.58 | 3.2 | -9.78 | -3.54 | -16.35 | -11.24 |
Net Cash Flow | -5.12 | 51.75 | -69.17 | -8.67 | -74.87 | -63.09 |
Free Cash Flow | 41.57 | 46.01 | 70.16 | 60.15 | 49.01 | 72.97 |
Free Cash Flow Growth | -9.65% | -34.42% | 16.64% | 22.74% | -32.84% | -76.86% |
FCF Margin | 2.88% | 3.10% | 4.05% | 3.05% | 2.20% | 2.71% |
Free Cash Flow Per Share | 0.83 | 0.91 | 1.41 | 1.21 | 0.97 | 1.42 |
Levered Free Cash Flow | -40.96 | -71.49 | -248.94 | 62.02 | 453.72 | -50.17 |
Unlevered Free Cash Flow | -12.8 | -7.99 | -119.29 | -30.96 | 19.48 | -89.2 |